SETMELANOTIDE

SETMELANOTIDE was reported 285 times

SETMELANOTIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REACTIVE ANGIOENDOTHELIOMATOSIS 1 0.3333
1 HYPOTHALAMIC OBESITY 1 0.2500
2 LEPTIN LEVEL INCREASED 1 0.0909
3 OROPHARYNGEAL COBBLE STONE MUCOSA 1 0.0714
4 MALE GENITAL EXAMINATION ABNORMAL 1 0.0435
5 ENDOMETRIAL HYPERPLASIA WITH CELLULAR ATYPIA 1 0.0357
6 THYROID NODULE REMOVAL 1 0.0250
7 OLFACTORY DYSFUNCTION 1 0.0238
8 IRIS DISCOLOURATION 1 0.0217
9 MELANODERMA 4 0.0208
10 EPHELIDES 10 0.0185
11 OPTIC DISC DRUSEN 1 0.0159
12 EXERTIONAL HEADACHE 1 0.0156
13 SPONTANEOUS PENILE ERECTION 9 0.0145
14 DYSANIA 1 0.0130
15 RAOULTELLA ORNITHINOLYTICA INFECTION 1 0.0130
16 PIGMENTATION LIP 1 0.0093
17 OPTIC DISC OEDEMA 1 0.0086
18 CIRCUMCISION 1 0.0071
19 TANNING 1 0.0068
20 DIAPHRAGMATIC SPASM 1 0.0068
21 FEAR-RELATED AVOIDANCE OF ACTIVITIES 1 0.0066
22 UROBILINOGEN URINE INCREASED 1 0.0061
23 DYSPLASTIC NAEVUS 2 0.0055
24 BLOOD KETONE BODY PRESENT 1 0.0053
25 BLOOD TEST 1 0.0053
26 HERNIA HIATUS REPAIR 1 0.0049
27 SKIN HYPERPIGMENTATION 42 0.0049
28 INJECTION SITE PLAQUE 1 0.0048
29 MELANOCYTIC NAEVUS 20 0.0046
30 NAIL PIGMENTATION 1 0.0041
31 DELAYED PUBERTY 1 0.0039
32 DUMPING SYNDROME 1 0.0038
33 OESOPHAGEAL FOOD IMPACTION 2 0.0036
34 GENERALISED PUSTULAR PSORIASIS 1 0.0034
35 INJECTION SITE HYPERTROPHY 1 0.0031
36 CENTRAL HYPOTHYROIDISM 1 0.0030
37 BENIGN NEOPLASM OF SKIN 1 0.0030
38 DIAPHRAGMALGIA 1 0.0029
39 MUSCLE HYPERTROPHY 1 0.0028
40 FIBROUS HISTIOCYTOMA 1 0.0028
41 EAR OPERATION 1 0.0027
42 INTRACRANIAL TUMOUR HAEMORRHAGE 1 0.0026
43 FAT TISSUE DECREASED 1 0.0026
44 BONE DENSITY INCREASED 1 0.0025
45 DRUG TITRATION ERROR 6 0.0023
46 SARCOPENIA 1 0.0023
47 HAEMANGIOMA OF SKIN 1 0.0023
48 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 2 0.0023
49 REFUSAL OF TREATMENT BY RELATIVE 1 0.0022
50 BODY HEIGHT INCREASED 1 0.0020
51 WEIGHT LOSS POOR 10 0.0020
52 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
53 INTERTRIGO 1 0.0018
54 BURNOUT SYNDROME 1 0.0018
55 PRECOCIOUS PUBERTY 1 0.0018
56 LIP DISCOLOURATION 2 0.0016
57 ENDOMETRIAL ADENOCARCINOMA 1 0.0016
58 THYROXINE FREE INCREASED 1 0.0016
59 PAINFUL ERECTION 1 0.0015
60 OPHTHALMIC MIGRAINE 1 0.0014
61 FLUID IMBALANCE 1 0.0014
62 OVARIAN MASS 1 0.0014
63 PRECANCEROUS SKIN LESION 2 0.0014
64 PHIMOSIS 1 0.0014
65 SOFT TISSUE INJURY 1 0.0013
66 SENSITISATION 1 0.0013
67 PRODUCT INEFFECTIVE 1 0.0013
68 CROUP INFECTIOUS 1 0.0013
69 RETINAL PIGMENTATION 1 0.0013
70 VITAMIN B12 INCREASED 1 0.0013
71 DIABETES INSIPIDUS 3 0.0012
72 SKIN BACTERIAL INFECTION 1 0.0012
73 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
74 TONSILLECTOMY 2 0.0012
75 AMAUROSIS 1 0.0012
76 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
77 SOLILOQUY 1 0.0012
78 JAW OPERATION 1 0.0011
79 FIBROMA 1 0.0011
80 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
81 SOLAR LENTIGO 1 0.0011
82 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
83 BINGE EATING 1 0.0009
84 AORTIC DILATATION 1 0.0009
85 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
86 HUNGER 12 0.0009
87 DEVICE DISPENSING ERROR 1 0.0008
88 INJECTION SITE NODULE 9 0.0008
89 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
90 RENAL ATROPHY 1 0.0008
91 BILIARY OBSTRUCTION 1 0.0008
92 FEELINGS OF WORTHLESSNESS 1 0.0008
93 FOOD CRAVING 4 0.0008
94 FEELING GUILTY 1 0.0008
95 HYPERPHAGIA 3 0.0008
96 HALLUCINATIONS, MIXED 3 0.0007
97 CULTURE URINE POSITIVE 1 0.0007
98 INJECTION SITE HYPOAESTHESIA 1 0.0007
99 NOROVIRUS INFECTION 1 0.0007
100 SLEEP PARALYSIS 1 0.0007
101 IMPETIGO 1 0.0007
102 INFECTIOUS PLEURAL EFFUSION 1 0.0007
103 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
104 VIOLENCE-RELATED SYMPTOM 1 0.0006
105 NEOPLASM SKIN 1 0.0006
106 SUBSTANCE USE 1 0.0006
107 INCREASED APPETITE 12 0.0006
108 SHOULDER FRACTURE 1 0.0006
109 MEDICAL PROCEDURE 1 0.0006
110 EROSIVE OESOPHAGITIS 1 0.0006
111 SEIZURE LIKE PHENOMENA 1 0.0006
112 PRIAPISM 2 0.0006
113 HYPOPITUITARISM 1 0.0006
114 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
115 HYPERSEXUALITY 1 0.0005
116 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
117 SINUS NODE DYSFUNCTION 1 0.0005
118 SKIN DISCOLOURATION 25 0.0005
119 NARCOLEPSY 1 0.0005
120 MENOMETRORRHAGIA 1 0.0005
121 THYROID MASS 2 0.0005
122 RHEUMATIC DISORDER 1 0.0005
123 EARLY SATIETY 1 0.0005
124 DEREALISATION 1 0.0005
125 GASTRIC BYPASS 1 0.0005
126 PRODUCT PREPARATION ISSUE 3 0.0005
127 DISCOURAGEMENT 1 0.0004
128 HYPERNATRAEMIA 2 0.0004
129 FLUID INTAKE REDUCED 2 0.0004
130 TONSILLITIS 2 0.0004
131 PERSONALITY DISORDER 1 0.0004
132 ORAL FUNGAL INFECTION 1 0.0004
133 HYPOMENORRHOEA 1 0.0004
134 INJECTION SITE SCAR 1 0.0004
135 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
136 GROWTH RETARDATION 1 0.0003
137 CEREBROVASCULAR DISORDER 1 0.0003
138 PIGMENTATION DISORDER 2 0.0003
139 INTENTIONAL DOSE OMISSION 9 0.0003
140 INJECTION SITE IRRITATION 4 0.0003
141 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
142 INITIAL INSOMNIA 3 0.0003
143 REGURGITATION 1 0.0003
144 CERVICAL VERTEBRAL FRACTURE 1 0.0003
145 HYPOPHAGIA 7 0.0003
146 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
147 RHINOVIRUS INFECTION 1 0.0003
148 MUSCLE RUPTURE 1 0.0003
149 NAIL DISCOLOURATION 1 0.0003
150 ENURESIS 1 0.0002
151 ADRENAL INSUFFICIENCY 3 0.0002
152 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
153 SOCIAL PROBLEM 1 0.0002
154 THYROID FUNCTION TEST ABNORMAL 1 0.0002
155 ERECTION INCREASED 1 0.0002
156 SELF-INJURIOUS IDEATION 1 0.0002
157 MUSCLE FATIGUE 1 0.0002
158 TEARFULNESS 1 0.0002
159 TONGUE DISCOLOURATION 1 0.0002
160 INJECTION SITE PRURITUS 15 0.0002
161 THERAPY INTERRUPTED 16 0.0002
162 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
163 LOCALISED OEDEMA 1 0.0002
164 SUBCUTANEOUS ABSCESS 1 0.0002
165 PARAESTHESIA ORAL 3 0.0002
166 AFFECT LABILITY 2 0.0002
167 PHARYNGEAL SWELLING 2 0.0002
168 INJECTION SITE URTICARIA 5 0.0002
169 INJECTION SITE INFLAMMATION 1 0.0002
170 PROTEIN URINE PRESENT 1 0.0002
171 ERYSIPELAS 1 0.0002
172 WEIGHT FLUCTUATION 2 0.0002
173 PARTIAL SEIZURES 1 0.0002
174 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
175 HIP SURGERY 1 0.0002
176 FAECALOMA 1 0.0002
177 INTERMENSTRUAL BLEEDING 1 0.0002
178 STATUS EPILEPTICUS 2 0.0002
179 HYPERVENTILATION 1 0.0002
180 HYPOVOLAEMIA 1 0.0002
181 HYPERTRIGLYCERIDAEMIA 1 0.0002
182 THIRST 3 0.0002
183 TYPE 1 DIABETES MELLITUS 1 0.0002
184 SCOLIOSIS 1 0.0002
185 AGGRESSION 8 0.0002
186 INCOHERENT 1 0.0002
187 INJECTION SITE INDURATION 2 0.0002
188 SKIN MASS 1 0.0001
189 BREAST MASS 1 0.0001
190 POSTOPERATIVE WOUND INFECTION 1 0.0001
191 SINUS CONGESTION 2 0.0001
192 ANGER 5 0.0001
193 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
194 ABNORMAL LOSS OF WEIGHT 1 0.0001
195 BLOOD TESTOSTERONE DECREASED 1 0.0001
196 LYMPHOEDEMA 1 0.0001
197 AUTOIMMUNE HEPATITIS 1 0.0001
198 FEAR OF INJECTION 1 0.0001
199 FAECES SOFT 1 0.0001
200 APATHY 2 0.0001
201 MAJOR DEPRESSION 1 0.0001
202 DEPRESSED MOOD 7 0.0001
203 LIPASE INCREASED 1 0.0001
204 ANKLE FRACTURE 2 0.0001
205 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
206 RENAL CYST 1 0.0001
207 INJECTION SITE BRUISING 10 0.0001
208 MUSCLE DISORDER 1 0.0001
209 BLOOD POTASSIUM INCREASED 2 0.0001
210 POST PROCEDURAL INFECTION 1 0.0001
211 MENSTRUAL DISORDER 1 0.0001
212 FACIAL PARALYSIS 1 0.0001
213 ANURIA 1 0.0001
214 MENTAL DISORDER 5 0.0001
215 INJECTION SITE ERYTHEMA 14 0.0001
216 HEAVY MENSTRUAL BLEEDING 1 0.0001
217 DIARRHOEA HAEMORRHAGIC 1 0.0001
218 FLANK PAIN 1 0.0001
219 PHOTOPHOBIA 2 0.0001
220 BLOOD SODIUM DECREASED 2 0.0001
221 INTENTIONAL SELF-INJURY 2 0.0001
222 HYPOTHERMIA 1 0.0001
223 ILLNESS 10 0.0001
224 INJECTION SITE DISCOMFORT 1 0.0001
225 INCONTINENCE 1 0.0001
226 MOOD SWINGS 3 0.0001
227 RETCHING 2 0.0001
228 WEIGHT INCREASED 21 0.0001
229 DECREASED ACTIVITY 1 0.0001
230 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
231 BIPOLAR DISORDER 1 0.0001
232 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
233 MALNUTRITION 1 0.0001
234 SKIN INFECTION 1 0.0001
235 INTESTINAL PERFORATION 1 0.0001
236 CHROMATURIA 2 0.0001
237 SUICIDAL IDEATION 8 0.0001
238 POST PROCEDURAL HAEMORRHAGE 1 0.0001
239 HYPOXIA 3 0.0001
240 BACTERAEMIA 1 0.0001
241 MYOCLONUS 1 0.0001
242 CRYING 3 0.0001
243 HYPOGLYCAEMIA 4 0.0001
244 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
245 SMALL INTESTINAL OBSTRUCTION 1 0.0001
246 INJECTION SITE MASS 3 0.0001
247 HYPERCALCAEMIA 1 0.0001
248 PHARYNGITIS 1 0.0001
249 HAIR COLOUR CHANGES 1 0.0001
250 INJECTION SITE DISCOLOURATION 1 0.0001
251 INTRAOCULAR PRESSURE INCREASED 1 0.0001
252 HOSPITALISATION 12 0.0001
253 NODULE 1 0.0001
254 SARS-COV-2 TEST POSITIVE 1 0.0001
255 ABNORMAL BEHAVIOUR 3 0.0001
256 ADVERSE REACTION 1 0.0001
257 EAR INFECTION 2 0.0001
258 HAIR TEXTURE ABNORMAL 1 0.0001
259 THROAT TIGHTNESS 2 0.0001
260 IMPAIRED GASTRIC EMPTYING 1 0.0001
261 TREATMENT NONCOMPLIANCE 4 0.0001
262 FEELING COLD 2 0.0001
263 HYPOMAGNESAEMIA 1 0.0001
264 APHONIA 1 0.0001
265 HYPONATRAEMIA 4 0.0001
266 SKIN REACTION 1 0.0001
267 SLEEP DISORDER 5 0.0001
268 SEASONAL ALLERGY 1 0.0001
269 BRONCHOSPASM 1 0.0001
270 DECREASED APPETITE 16 0.0001
271 GASTROENTERITIS 1 0.0001
272 SURGERY 4 0.0001
273 NAUSEA 54 0.0001
274 AGITATION 5 0.0001
275 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
276 BLOOD POTASSIUM DECREASED 2 0.0001
277 HYPOAESTHESIA ORAL 1 0.0001
278 OFF LABEL USE 58 0.0001
279 EPILEPSY 2 0.0001
280 INJECTION SITE SWELLING 5 0.0001
281 FEELING HOT 4 0.0001
282 DEVICE RELATED INFECTION 1 0.0001
283 THYROID DISORDER 1 0.0001
284 DELUSION 1 0.0001
285 BASAL CELL CARCINOMA 1 0.0001
286 VOMITING 30 0.0001
287 HALLUCINATION, AUDITORY 1 0.0001
288 DRUG INTOLERANCE 6 0.0001
289 CHOLELITHIASIS 2 0.0001
290 MANIA 1 0.0001
291 VISUAL ACUITY REDUCED 2 0.0001
292 ABDOMINAL PAIN 14 0.0001
293 URINARY RETENTION 2 0.0001
294 PERICARDITIS 1 0.0001
295 HEMIPARESIS 1 0.0001
296 FLUID RETENTION 3 0.0001
297 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
298 SCAR 1 0.0001
299 ABDOMINAL PAIN UPPER 12 0.0001
300 INJECTION SITE REACTION 4 0.0001
301 PARANOIA 1 0.0001
302 PRODUCT DOSE OMISSION ISSUE 17 0.0001
303 SYRINGE ISSUE 1 0.0001
304 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
305 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
306 HEAD DISCOMFORT 1 0.0001
307 GALLBLADDER DISORDER 1 0.0001
308 GASTROINTESTINAL DISORDER 5 0.0001
309 RESTLESS LEGS SYNDROME 1 0.0001
310 END STAGE RENAL DISEASE 1 0.0001
311 RESTLESSNESS 2 0.0001
312 SOMNOLENCE 11 0.0001
313 HEPATIC STEATOSIS 1 0.0001
314 THINKING ABNORMAL 1 0.0001
315 HEPATIC CIRRHOSIS 1 0.0001
316 HYPOCALCAEMIA 1 0.0001
317 SLEEP APNOEA SYNDROME 1 0.0001
318 HERNIA 1 0.0001
319 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
320 SINUS DISORDER 1 0.0001
321 SYNCOPE 5 0.0000
322 FEEDING DISORDER 1 0.0000
323 DISCOMFORT 3 0.0000
324 INJURY ASSOCIATED WITH DEVICE 1 0.0000
325 INJECTION SITE WARMTH 1 0.0000
326 HEADACHE 30 0.0000
327 EATING DISORDER 1 0.0000
328 IMPAIRED WORK ABILITY 1 0.0000
329 SKIN CANCER 1 0.0000
330 INFLUENZA 5 0.0000
331 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
332 SNEEZING 1 0.0000
333 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
334 PRODUCT AVAILABILITY ISSUE 1 0.0000
335 HYPOKALAEMIA 2 0.0000
336 SEIZURE 5 0.0000
337 OCULAR HYPERAEMIA 2 0.0000
338 DYSPHAGIA 4 0.0000
339 ABDOMINAL DISCOMFORT 7 0.0000
340 BLOOD PRESSURE FLUCTUATION 1 0.0000
341 DIABETIC KETOACIDOSIS 1 0.0000
342 LUNG DISORDER 2 0.0000
343 LIVER INJURY 1 0.0000
344 ENCEPHALOPATHY 1 0.0000
345 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
346 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
347 HEPATITIS 1 0.0000
348 ANAPHYLACTIC SHOCK 1 0.0000
349 UNRESPONSIVE TO STIMULI 1 0.0000
350 MUSCLE SPASMS 7 0.0000
351 JOINT STIFFNESS 1 0.0000
352 GASTRITIS 1 0.0000
353 PANCREATITIS 2 0.0000
354 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
355 JAUNDICE 1 0.0000
356 BLOOD BILIRUBIN INCREASED 1 0.0000
357 FREQUENT BOWEL MOVEMENTS 1 0.0000
358 PNEUMONITIS 1 0.0000
359 CONSTIPATION 8 0.0000
360 MOOD ALTERED 1 0.0000
361 SKIN LESION 1 0.0000
362 HAEMATOCHEZIA 2 0.0000
363 INJECTION SITE PAIN 11 0.0000
364 RENAL IMPAIRMENT 3 0.0000
365 FLATULENCE 2 0.0000
366 DEPRESSION 8 0.0000
367 ANGINA PECTORIS 1 0.0000
368 HYPERSOMNIA 1 0.0000
369 ASTHENIA 13 0.0000
370 LIVER FUNCTION TEST ABNORMAL 1 0.0000
371 PALPITATIONS 4 0.0000
372 CHILLS 4 0.0000
373 INSOMNIA 9 0.0000
374 TACHYCARDIA 3 0.0000
375 IRRITABILITY 2 0.0000
376 HEPATIC FAILURE 1 0.0000
377 APHASIA 1 0.0000
378 INJECTION SITE RASH 1 0.0000
379 NASOPHARYNGITIS 6 0.0000
380 DIARRHOEA 21 0.0000
381 LIMB DISCOMFORT 1 0.0000
382 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
383 HEAD INJURY 1 0.0000
384 METABOLIC ACIDOSIS 1 0.0000
385 RHINORRHOEA 2 0.0000
386 FATIGUE 24 0.0000
387 STAPHYLOCOCCAL INFECTION 1 0.0000
388 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
389 VIRAL INFECTION 1 0.0000
390 EYE PRURITUS 1 0.0000
391 MALAISE 13 0.0000
392 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
393 FLUSHING 3 0.0000
394 DELIRIUM 1 0.0000
395 HEART RATE DECREASED 1 0.0000
396 LYMPHADENOPATHY 1 0.0000
397 DIZZINESS 14 0.0000
398 PANIC ATTACK 1 0.0000
399 ACCIDENTAL OVERDOSE 1 0.0000
400 BRONCHITIS 2 0.0000
401 HYPERSENSITIVITY 5 0.0000
402 EYE SWELLING 1 0.0000
403 EPISTAXIS 2 0.0000
404 DYSARTHRIA 1 0.0000
405 ASTHMA 3 0.0000
406 HOT FLUSH 2 0.0000
407 INCORRECT DOSE ADMINISTERED 6 0.0000
408 COUGH 7 0.0000
409 ABORTION SPONTANEOUS 1 0.0000
410 HYPOTENSION 5 0.0000
411 DRY MOUTH 2 0.0000
412 BLINDNESS 1 0.0000
413 POLLAKIURIA 1 0.0000
414 CARDIO-RESPIRATORY ARREST 1 0.0000
415 MYALGIA 4 0.0000
416 PYREXIA 8 0.0000
417 VAGINAL HAEMORRHAGE 1 0.0000
418 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
419 DEHYDRATION 3 0.0000
420 COLITIS ULCERATIVE 1 0.0000
421 PULMONARY OEDEMA 1 0.0000
422 ADVERSE DRUG REACTION 2 0.0000
423 THERAPY NON-RESPONDER 1 0.0000
424 NEPHROLITHIASIS 1 0.0000
425 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
426 CHEST PAIN 4 0.0000
427 BACK PAIN 5 0.0000
428 WEIGHT DECREASED 6 0.0000
429 PRODUCT USE ISSUE 4 0.0000
430 FALL 7 0.0000
431 RASH ERYTHEMATOUS 1 0.0000
432 ATRIAL FIBRILLATION 2 0.0000
433 DYSPEPSIA 2 0.0000
434 HEART RATE INCREASED 2 0.0000
435 HYPOAESTHESIA 3 0.0000
436 CELLULITIS 1 0.0000
437 CHEST DISCOMFORT 2 0.0000
438 THERAPY CESSATION 1 0.0000
439 ERYTHEMA 4 0.0000
440 INFLAMMATION 1 0.0000
441 ARTHRALGIA 8 0.0000
442 ABDOMINAL DISTENSION 2 0.0000
443 ECZEMA 1 0.0000
444 SPEECH DISORDER 1 0.0000
445 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
446 OVERDOSE 4 0.0000
447 RASH PRURITIC 1 0.0000
448 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
449 ANAPHYLACTIC REACTION 1 0.0000
450 ARTHROPATHY 1 0.0000
451 MEDICATION ERROR 1 0.0000
452 OXYGEN SATURATION DECREASED 1 0.0000
453 URINARY TRACT INFECTION 3 0.0000
454 ANXIETY 5 0.0000
455 BONE PAIN 1 0.0000
456 NASAL CONGESTION 1 0.0000
457 DISEASE PROGRESSION 2 0.0000
458 FEELING ABNORMAL 4 0.0000
459 PLEURAL EFFUSION 1 0.0000
460 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
461 ANAEMIA 3 0.0000
462 LOSS OF CONSCIOUSNESS 2 0.0000
463 PNEUMONIA 5 0.0000
464 SWELLING FACE 1 0.0000
465 ALOPECIA 3 0.0000
466 HEPATIC ENZYME INCREASED 1 0.0000
467 INJURY 1 0.0000
468 INFECTION 2 0.0000
469 UNDERDOSE 1 0.0000
470 DYSGEUSIA 1 0.0000
471 BLOOD PRESSURE INCREASED 2 0.0000
472 PRURITUS 5 0.0000
473 ARTHRITIS 1 0.0000
474 DRUG INTERACTION 2 0.0000
475 CARDIAC FAILURE 1 0.0000
476 INFLUENZA LIKE ILLNESS 1 0.0000
477 CARDIAC ARREST 1 0.0000
478 TREMOR 2 0.0000
479 URTICARIA 2 0.0000
480 BALANCE DISORDER 1 0.0000
481 PRODUCT STORAGE ERROR 1 0.0000
482 COVID-19 2 0.0000
483 PAIN 7 0.0000
484 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
485 ADVERSE EVENT 1 0.0000
486 OROPHARYNGEAL PAIN 1 0.0000
487 CARDIAC DISORDER 1 0.0000
488 DYSPNOEA 6 0.0000
489 PULMONARY EMBOLISM 1 0.0000
490 NEUROPATHY PERIPHERAL 1 0.0000
491 MIGRAINE 1 0.0000
492 GAIT DISTURBANCE 2 0.0000
493 PAIN IN EXTREMITY 3 0.0000
494 DRUG INEFFECTIVE 13 0.0000
495 SINUSITIS 1 0.0000
496 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
497 SEPSIS 1 0.0000
498 MUSCULAR WEAKNESS 1 0.0000
499 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
500 EMOTIONAL DISTRESS 1 0.0000
501 OEDEMA PERIPHERAL 1 0.0000
502 VISUAL IMPAIRMENT 1 0.0000
503 HYPERHIDROSIS 1 0.0000
504 PSORIASIS 1 0.0000
505 RENAL FAILURE 1 0.0000
506 DRY SKIN 1 0.0000
507 VISION BLURRED 1 0.0000
508 CONDITION AGGRAVATED 2 0.0000
509 ACUTE KIDNEY INJURY 1 0.0000
510 PERIPHERAL SWELLING 1 0.0000
511 PARAESTHESIA 1 0.0000
512 CONFUSIONAL STATE 1 0.0000
513 CEREBROVASCULAR ACCIDENT 1 0.0000
514 NO ADVERSE EVENT 1 0.0000
515 HYPERTENSION 1 0.0000
516 RASH 2 0.0000
517 DEATH 2 0.0000